
Biobanking Market Report 2024-2034
Description
Biobanking Market Report 2024-2034
The Biobanking Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing Investments and Funding Projected to Boost Industry Growth
Biobanks are experiencing increased acknowledgment and support from global governments, research bodies, and financial institutions, leading to a surge in investment in these facilities. Notably, initiatives like the Biorepository and Precision Medicine Initiative Cohort Program, funded by the U.S. National Institutes of Health (NIH), seek to amass biological samples from over a million individuals to establish a comprehensive national research resource. Concurrently, the European Commission has committed funding to the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European facility focused on biobanking and biomolecular resources. This heightened attention and financial backing underscore the strategic importance of biobanks in advancing scientific research and precision medicine on a global scale.
Hight Cost of Equipment Likely to Challenge Industry Growth
The market's growth potential is anticipated to face limitations due to the substantial expenses associated with automated equipment. While cutting-edge technologies like advanced sample handling systems have the potential to enhance operational efficiency and elevate the quality of biobanking processes, their high price tags pose a considerable challenge, particularly for smaller biobanking enterprises or those with constrained financial capacities. Take, for instance, the expenditure involved in acquiring an automated storage system, which can vary based on its size and complexity. The initial capital outlay for such systems can be substantial, ranging from tens of thousands to hundreds of thousands of dollars. Beyond the initial investment, ongoing considerations encompass maintenance and operational expenses, including software updates, repairs, and training. This cost factor serves as a strategic consideration for businesses evaluating the incorporation of automated equipment in their biobanking operations.
What Questions Should You Ask before Buying a Market Research Report?
- How is the biobanking market evolving?
- What is driving and restraining the biobanking market?
- How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each biobanking submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the biobanking projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of
biobanking projects taking place now and over the next 10 years? - Is there a greater need for product commercialisation to further scale the biobanking market?
- Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
- Our 264-page report provides 121 tables and 182 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
- National/Regional Agencies
- Universities
- Non-profit
- Private
- Equipment
- Consumables
- Services
- Software
- Blood Products
- Human Tissues
- Nucleic Acids
- Cell Lines
- Biological Fluids
- Others
- Regenerative Medicine
- Life Science Research
- Clinical Research
- Pharmaceutical & Biotechnology Companies
- CROs
- Academic & Research Institutes
- Hospitals
- U.S.
- Canada
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- South-East Asia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of MEA
- ASKION GmbH
- Avantor Inc.
- Azenta Inc.
- Boca Biolistics
- BIOIVT & ELEVATING SCIENCE
- Cryoport Inc.
- CTI Biotech
- Hamilton Company
- Isenet Biobanking
- Merck & Co., Inc.
- PHC Holdings Corporation
- ProteoGenex Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Tecan Trading AG
- US Biolab Corp. Inc.
- Revenue forecasts to 2034 for Biobanking Market 2024 to 2034, with forecasts for ownership, product and service, sample, application, end-users each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 22 key national markets – See forecasts for the Biobanking Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Biobanking Market, 2024 to 2034.
Forecasts to 2034 and other analyses reveal commercial prospects
Segments Covered in the Report
Ownership
North America
Leading companies profiled in the report
How will the Biobanking Market, 2024 to 2034 report help you?
In summary, our 260+ page report provides you with the following knowledge:
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biobanking Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..
The publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.
Table of Contents
264 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Biobanking Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing
- 3.2.1.2 Growing Demand for Umbilical Cord Blood Banking
- 3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues
- 3.2.2.2 Issues Related to Biospecimen Sample Procurement
- 3.2.2.3 Long-term Sustainability of Biobanks
- 3.2.3 Market Opportunities
- 3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment
- 3.2.3.2 Opportunities for Cardiovascular Research
- 3.2.3.3 Growing Focus on the R&D of Cell Therapies
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter’s Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat of Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
- 4 Biobanking Market Analysis by Ownership
- 4.1 Key Findings
- 4.2 Ownership Segment: Market Attractiveness Index
- 4.3 Biobanking Market Size Estimation and Forecast by Ownership
- 4.4 National/Regional Agencies
- 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2024 & 2034 (%)
- 4.5 Universities
- 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2024 & 2034 (%)
- 4.6 Non-profit
- 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.6.2 Market Share by Region, 2024 & 2034 (%)
- 4.7 Private
- 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 4.7.2 Market Share by Region, 2024 & 2034 (%)
- 5 Biobanking Market Analysis by Sample
- 5.1 Key Findings
- 5.2 Sample Segment: Market Attractiveness Index
- 5.3 Biobanking Market Size Estimation and Forecast by Sample
- 5.4 Blood Products
- 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2024 & 2034 (%)
- 5.5 Human Tissues
- 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2024 & 2034 (%)
- 5.6 Nucleic Acids
- 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2024 & 2034 (%)
- 5.7 Cell Lines
- 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.7.2 Market Share by Region, 2024 & 2034 (%)
- 5.8 Biological Fluids
- 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.8.2 Market Share by Region, 2024 & 2034 (%)
- 5.9 Others
- 5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 5.9.2 Market Share by Region, 2024 & 2034 (%)
- 6 Biobanking Market Analysis by Application
- 6.1 Key Findings
- 6.2 Application Segment: Market Attractiveness Index
- 6.3 Biobanking Market Size Estimation and Forecast by Application
- 6.4 Regenerative Medicine
- 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.4.2 Market Share by Region, 2024 & 2034 (%)
- 6.5 Life Science Research
- 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.5.2 Market Share by Region, 2024 & 2034 (%)
- 6.6 Clinical Research
- 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 6.6.2 Market Share by Region, 2024 & 2034 (%)
- 7 Biobanking Market Analysis by Product and Service
- 7.1 Key Findings
- 7.2 Product and Service Segment: Market Attractiveness Index
- 7.3 Biobanking Market Size Estimation and Forecast by Product and Service
- 7.4 Equipment
- 7.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 7.4.2 Market Share by Region, 2024 & 2034 (%)
- 7.5 Consumables
- 7.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 7.5.2 Market Share by Region, 2024 & 2034 (%)
- 7.6 Services
- 7.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 7.6.2 Market Share by Region, 2024 & 2034 (%)
- 7.7 Software
- 7.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 7.7.2 Market Share by Region, 2024 & 2034 (%)
- 8 Biobanking Market Analysis by End-users
- 8.1 Key Findings
- 8.2 End-users Segment: Market Attractiveness Index
- 8.3 Biobanking Market Size Estimation and Forecast by End-users
- 8.4 Pharmaceutical & Biotechnology Companies
- 8.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 8.4.2 Market Share by Region, 2024 & 2034 (%)
- 8.5 CROs
- 8.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 8.5.2 Market Share by Region, 2024 & 2034 (%)
- 8.6 Academic & Research Institutes
- 8.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 8.6.2 Market Share by Region, 2024 & 2034 (%)
- 8.7 Hospitals
- 8.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
- 8.7.2 Market Share by Region, 2024 & 2034 (%)
- 9 Biobanking Market Analysis by Region
- 9.1 Key Findings
- 9.2 Regional Market Size Estimation and Forecast
- 10 North America Biobanking Market Analysis
- 10.1 Key Findings
- 10.2 North America Biobanking Market Attractiveness Index
- 10.3 North America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 10.4 North America Biobanking Market Size Estimation and Forecast by Country
- 10.5 North America Biobanking Market Size Estimation and Forecast by Ownership
- 10.6 North America Biobanking Market Size Estimation and Forecast by Sample
- 10.7 North America Biobanking Market Size Estimation and Forecast by Application
- 10.8 North America Biobanking Market Size Estimation and Forecast by Product and Service
- 10.9 North America Biobanking Market Size Estimation and Forecast by End-users
- 10.10 U.S. Biobanking Market Analysis
- 10.11 Canada Biobanking Market Analysis
- 11 Europe Biobanking Market Analysis
- 11.1 Key Findings
- 11.2 Europe Biobanking Market Attractiveness Index
- 11.3 Europe Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 11.4 Europe Biobanking Market Size Estimation and Forecast by Country
- 11.5 Europe Biobanking Market Size Estimation and Forecast by Ownership
- 11.6 Europe Biobanking Market Size Estimation and Forecast by Sample
- 11.7 Europe Biobanking Market Size Estimation and Forecast by Application
- 11.8 Europe Biobanking Market Size Estimation and Forecast by Product and Service
- 11.9 Europe Biobanking Market Size Estimation and Forecast by End-users
- 11.10 Germany Biobanking Market Analysis
- 11.11 UK Biobanking Market Analysis
- 11.12 France Biobanking Market Analysis
- 11.13 Italy Biobanking Market Analysis
- 11.14 Spain Biobanking Market Analysis
- 11.15 Russia Biobanking Market Analysis
- 11.16 Rest of Europe Biobanking Market Analysis
- 12 Asia Pacific Biobanking Market Analysis
- 12.1 Key Findings
- 12.2 Asia Pacific Biobanking Market Attractiveness Index
- 12.3 Asia Pacific Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 12.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country
- 12.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership
- 12.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample
- 12.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application
- 12.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Product and Service
- 12.9 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users
- 12.10 Japan Biobanking Market Analysis
- 12.11 China Biobanking Market Analysis
- 12.12 India Biobanking Market Analysis
- 12.13 Australia Biobanking Market Analysis
- 12.14 South Korea Biobanking Market Analysis
- 12.15 South-East Asia Biobanking Market Analysis
- 12.16 Rest of Asia Pacific Biobanking Market Analysis
- 13 Latin America Biobanking Market Analysis
- 13.1 Key Findings
- 13.2 Latin America Biobanking Market Attractiveness Index
- 13.3 Latin America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 13.4 Latin America Biobanking Market Size Estimation and Forecast by Country
- 13.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership
- 13.6 Latin America Biobanking Market Size Estimation and Forecast by Sample
- 13.7 Latin America Biobanking Market Size Estimation and Forecast by Application
- 13.8 Latin America Biobanking Market Size Estimation and Forecast by Product and Service
- 13.9 Latin America Biobanking Market Size Estimation and Forecast by End-users
- 13.10 Brazil Biobanking Market Analysis
- 13.11 Mexico Biobanking Market Analysis
- 13.12 Rest of Latin America Biobanking Market Analysis
- 14 MEA Biobanking Market Analysis
- 14.1 Key Findings
- 14.2 MEA Biobanking Market Attractiveness Index
- 14.3 MEA Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)
- 14.4 MEA Biobanking Market Size Estimation and Forecast by Country
- 14.5 MEA Biobanking Market Size Estimation and Forecast by Ownership
- 14.6 MEA Biobanking Market Size Estimation and Forecast by Sample
- 14.7 MEA Biobanking Market Size Estimation and Forecast by Application
- 14.8 MEA Biobanking Market Size Estimation and Forecast by Product and Service
- 14.9 MEA Biobanking Market Size Estimation and Forecast by End-users
- 14.10 GCC Biobanking Market Analysis
- 14.11 South Africa Biobanking Market Analysis
- 14.12 Rest of MEA Biobanking Market Analysis
- 15 Company Profiles
- 15.1 Thermo Fisher Scientific, Inc.
- 15.1.1 Company Snapshot
- 15.1.2 Company Overview
- 15.1.3 Financial Analysis
- 15.1.3.1 Net Revenue, 2015-2022
- 15.1.3.2 Regional Market Shares, 2022
- 15.1.3.3 R&D, 2015-2022
- 15.1.4 Product Benchmarking
- 15.2 PHC Holdings Corporation
- 15.2.1 Company Snapshot
- 15.2.2 Company Overview
- 15.2.3 Product Benchmarking
- 15.2.4 Strategic Outlook
- 15.3 Hamilton Company
- 15.3.1 Company Snapshot
- 15.3.2 Company Overview
- 15.3.3 Product Benchmarking
- 15.4 Avantor Inc.
- 15.4.1 Company Snapshot
- 15.4.2 Company Overview
- 15.4.3 Financial Analysis
- 15.4.3.1 Net Revenue, 2015-2022
- 15.4.3.2 Regional Market Shares, 2022
- 15.4.4 Product Benchmarking
- 15.5 Qiagen N.V.
- 15.5.1 Company Snapshot
- 15.5.2 Company Overview
- 15.5.3 Financial Analysis
- 15.5.3.1 Net Revenue, 2015-2022
- 15.5.3.2 Regional Market Shares, 2022
- 15.5.3.3 R&D, 2015-2022
- 15.5.4 Product Benchmarking
- 15.6 Tecan Trading AG
- 15.6.1 Company Snapshot
- 15.6.2 Company Overview
- 15.6.3 Product Benchmarking
- 15.7 Merck & Co., Inc.
- 15.7.1 Company Snapshot
- 15.7.2 Company Overview
- 15.7.3 Financial Analysis
- 15.7.3.1 Net Revenue, 2015-2022
- 15.7.3.2 Regional Market Shares, 2022
- 15.7.3.3 R&D, 2015-2022
- 15.7.4 Product Benchmarking
- 15.8 Cryoport Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Company Overview
- 15.8.3 Financial Analysis
- 15.8.3.1 Net Revenue, 2015-2022
- 15.8.3.2 Regional Market Shares, 2022
- 15.8.3.3 R&D, 2015-2022
- 15.8.4 Product Benchmarking
- 15.8.5 Strategic Outlook
- 15.9 Azenta Inc.
- 15.9.1 Company Snapshot
- 15.9.2 Company Overview
- 15.9.3 Financial Analysis
- 15.9.3.1 Net Revenue, 2015-2022
- 15.9.3.2 R&D, 2015-2022
- 15.9.4 Product Benchmarking
- 15.10 Isenet Biobanking
- 15.10.1 Company Snapshot
- 15.10.2 Company Overview
- 15.10.3 Product Benchmarking
- 15.11 CTI Biotech
- 15.11.1 Company Snapshot
- 15.11.2 Company Overview
- 15.11.3 Product Benchmarking
- 15.12 Boca Biolistics
- 15.12.1 Company Snapshot
- 15.12.2 Company Overview
- 15.12.3 Product Benchmarking
- 15.12.4 Strategic Outlook
- 15.13 BIOIVT & ELEVATING SCIENCE
- 15.13.1 Company Snapshot
- 15.13.2 Company Overview
- 15.13.3 Product Benchmarking
- 15.13.4 Strategic Outlook
- 15.14 US Biolab Corp. Inc.
- 15.14.1 Company Snapshot
- 15.14.2 Company Overview
- 15.14.3 Product Benchmarking
- 15.15 ProteoGenex Inc.
- 15.15.1 Company Snapshot
- 15.15.2 Company Overview
- 15.15.3 Product Benchmarking
- 15.16 ASKION GmbH
- 15.16.1 Company Snapshot
- 15.16.2 Company Overview
- 15.16.3 Product Benchmarking
- 16 Conclusion and Recommendations
- 16.1 Concluding Remarks from Visiongain
- 16.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.